Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Intangibles (2021 - 2022)

Whitehawk Therapeutics (WHWK) has disclosed Intangibles for 2 consecutive years, with $3.7 million as the latest value for Q1 2022.

  • On a quarterly basis, Intangibles changed N/A to $3.7 million in Q1 2022 year-over-year; TTM through Mar 2022 was $3.7 million, a N/A change, with the full-year FY2021 number at $3.8 million, changed N/A from a year prior.
  • Intangibles was $3.7 million for Q1 2022 at Whitehawk Therapeutics, down from $3.8 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $3.8 million in Q4 2021 to a low of $3.7 million in Q1 2022.